Highlights and Quick Summary
- Change in payables and accrued liability for the quarter ending September 30, 2023 was $505 Thousand (a -225.31% decrease compared to previous quarter)
- Year-over-year quarterly Change in payables and accrued liability decreased by -26.92%
- Annual Change in payables and accrued liability for 2022 was $-533 Thousand (a -133.86% decrease from previous year)
- Annual Change in payables and accrued liability for 2021 was $1.57 Million (a 74.31% increase from previous year)
- Annual Change in payables and accrued liability for 2020 was $903 Thousand (a 1001.22% increase from previous year)
- Twelve month Change in payables and accrued liability ending September 30, 2023 was $311 Thousand (a -114.97% decrease compared to previous quarter)
- Twelve month trailing Change in payables and accrued liability decreased by -104.92% year-over-year
Trailing Change in payables and accrued liability for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $311 Thousand | $-2.08 Million | $-2.28 Million | $-6.32 Million |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Change in payables and accrued liability of Absci Corporation
Most recent Change in payables and accrued liabilityof ABSI including historical data for past 10 years.Interactive Chart of Change in payables and accrued liability of Absci Corporation
Absci Corporation Change in payables and accrued liability for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.51 | $-0.4 | $-0.48 | – | – |
| 2022 | $0.69 | $-1.88 | $-0.6 | $-4.53 | $-0.53 |
| 2021 | $2.15 | $-1.16 | $-0.85 | $0.44 | $1.57 |
| 2020 | $1.01 | $0.09 | $0.08 | $-0.13 | $0.9 |
| 2019 | – | – | – | – | $0.08 |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology